Dec 16, 2016
NCT02863991: Phase 1/2: Oral ONC201 in Relapsed/Refractory Multiple Myeloma
NCT02863991: Phase 1/2: Oral ONC201 in Relapsed/Refractory Multiple Myeloma ONC201 is an orally bioavailable first-in-class small...
57
top of page
Posts Archive
bottom of page